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Antonio Colombo, MD,y Neil Ruparelia, DPHILyzSEE PAGE 39E ver since percutaneous coronary intervention(PCI) was ﬁrst undertaken, bifurcation lesions,which account for up to 20% of all PCIs (1),
have presented a technical challenge (2). The optimal
strategy for the management of bifurcation lesions
has been the subject of intense investigation, with
single stent (or provisional) strategies being compared
with side branch (SB) protection and 2-stent strategies
(3). Leaving the 2-stent strategy aside, when a provi-
sional strategy is opted for, an important decision
that needs to be made is whether to place a wire in
the SB to facilitate access in case of severe compro-
mise or total occlusion. The 2 extreme options would
be to perform wire protection of all SB or in only a
select minority. Therefore, the ability to have a readily
available angiographic tool to predict SB occlusion
during bifurcation stenting is both attractive and
very welcome. Ideally, this information should allow
the operator to more accurately select the SB that
needs protection, which would maximize resource
and time utilization without compromising safety.
An important concept that needs to be highlighted at
the beginning is that SB protection can be performed
either by preventative stenting or by wire protection
alone. Depending on the appearances of the SB
following main vessel (MV) stenting, with a wire in
the SB, one could opt to: 1) do nothing at all; 2)
perform SB balloon dilation; or 3) crossover to stent
implantation.
In this issue of JACC: Cardiovascular Interventions,
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in coronary bifurcation intervention), to evaluate the
risk of SB occlusion in coronary artery bifurcation
intervention. From a cohort of 7,007 consecutive pa-
tients that underwent PCI over a 6-month period,
1,545 patients with 1,601 bifurcation lesions were
identiﬁed who were deﬁned as having coronary ar-
tery narrowing adjacent to or involving the origin of
a signiﬁcant SB. Importantly, as the authors point
out, the deﬁnition of an important SB was on the basis
of the functional importance placed on the lesion
rather than its reference diameter. Patients were
excluded if they underwent elective SB stenting
before MV stenting; 1,200 lesions were used in the
construction of the risk model, and the remaining 401
lesions were used to test and validate the model.The ﬁrst observation we would like to highlight
is that 290 patients (18.8%) presenting with bifur-
cations underwent elective SB stenting. The reasons
for the choice of this strategy in this patient group
have not been reported, and it is also unclear if in-
travascular imaging techniques were used to deter-
mine an initial provisional stenting strategy (5,6).
However, it does demonstrate that, in certain in-
stances, there are clear indications for SB stenting
with no uncertainty with regards to the best in-
terventional strategy. We will not consider these
scenarios in our further discussion.
A number of ﬁndings of the study warrant further
consideration. We assume, even if not stated, that
wire protection of the SB was performed sparingly.
SB occlusion occurred in 118 bifurcations of the 1,601
included in the initial analysis (7.37%) and resulted
in permanent occlusion in 98 cases (83%) and, thus,
myocardial injury. What would have been the
outcome if a wire had protected the SB in these pa-
tients? In this patient cohort, 14 SBs would have
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48required protecting to possibly prevent 1 SB occlu-
sion. Fundamentally, the objective of this study is to
reasonably lower the number of patients in whom SB
protection is required by better selecting individuals
at the highest risk of occlusion. Again, it is important
to stress that protection of the side branch does
not always equate to preventative stenting, but the
presence of a wire in situ across the SB (even if jailed
by the MV stent) in the setting of occlusion can
facilitate recrossing and is usually feasible for sub-
sequent stent implantation if required.
Although the risk score developed by the authors
is interesting, we doubt that operators will try to
calculate the speciﬁc score routinely prior to or dur-
ing a procedure. However, further examination of
the characteristics of the SB that occluded provides
important information with regard to deﬁning “high-
risk” lesions and optimizing management strategy.
The authors found that a high plaque burden (Medina
classiﬁcation 1, 1, 1), Thrombolysis In Myocardial
Infarction ﬂow grade before stenting, inadvertent
dissection of the SB after pre-dilation of the MV, and
a small SB diameter in relation to the MV (MV:SB >2)
were all risk factors for occlusion. Interestingly, the
severity of stenosis, and not lesion length, was im-
portant in determining risk of occlusion. It is impor-
tant here to differentiate between the requirement to
stent a long lesion in a large SB (which would have
been excluded in this study) and a severe SB stenosis
that may only require wire protection, pre-dilation,
and occasional provisional stenting. Finally, con-
trary to intuition, an SB with an angle closer to 90 orlarger had a higher risk of occlusion, which suggests
mechanistically that SB occlusion may be caused
more frequently by plaque shift as opposed to carina
shift, which is likely to be more relevant in the setting
of a narrow bifurcation angle.
In this study, the majority of the SBs that occluded
did not have a protection wire placed at baseline
and did not undergo pre-dilation prior to MV stent-
ing. With regard to the latter point, although rou-
tine pre-dilation of an SB is not recommended and
may lead to unnecessary dissection, when the SB
has a severe ostial lesion, pre-dilation may be im-
portant and valuable in maintaining patency of the
vessel (7).
In conclusion, there is no “one-size-ﬁts-all” strat-
egy for the optimal management of bifurcation
lesions. The important message that this study pro-
vides is that all SBs do not require wire protection.
Although provisional stenting is the preferred strat-
egy if possible (8), in the presence of “high-risk”
features as deﬁned by this model, there should be a
very low threshold to protect the SB prior to MV stent
implantation. The risk of wire placement is easily
offset by the knowledge that successful restoration of
normal ﬂow is unlikely after occlusion of the SB
occurs, with resultant myocardial necrosis and worse
patient outcomes.
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